Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genta and NCI to collaborate on G-3139 development

July 7, 1998

Specific NE inhibitor effective against primary lung tumors and metastases in mice

July 6, 1998

Banyu isolates new antitumor substance from Streptomyces

July 6, 1998

NeoRx initiates phase I combination therapy trials in multiple myeloma patients

July 6, 1998

Spartaject busulfan enters phase I for pediatric BMT patients

July 3, 1998

Tridemethylthiocolchicine analogues as selective topoisomerase II inhibitors

July 2, 1998

Novel antitumor agents prepared at Kanebo

July 2, 1998

Favorable preliminary results for IntraDose in metastatic breast cancer and malignant melanoma

July 1, 1998

Different schedules, doses of DX-8951f assessed in phase I

July 1, 1998

TZT-1027: mechanism of action and phase I results

July 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...